Cargando…
Safety and Efficacy of Liver-Directed Radiotherapy in Combination With Lenvatinib for Hepatocelluar Carcinoma With Macroscopic Tumor Thrombosis
BACKGROUND: This study aimed to compare the clinical outcomes of patients with hepatocellular carcinoma (HCC) and macroscopic tumor thrombosis who were treated with lenvatinib with or without combined liver-directed radiotherapy (LRT). METHODS: From the institutional registry, we enrolled 82 patient...
Autores principales: | Yu, Jeong Il, Kang, Wonseok, Yoo, Gyu Sang, Goh, Myung Ji, Sinn, Dong Hyun, Gwak, Geum-Youn, Paik, Yong-Han, Choi, Moon Seok, Lee, Joon Hyeok, Koh, Kwang Cheol, Paik, Seung Woon, Hong, Jung Yong, Lim, Ho Yeong, Park, Boram, Park, Hee Chul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130955/ https://www.ncbi.nlm.nih.gov/pubmed/35646674 http://dx.doi.org/10.3389/fonc.2022.888755 |
Ejemplares similares
-
Advanced Stage Hepatocellular Carcinoma Successfully Treated with Transarterial Radioembolization and Multi-tyrosine Kinase Inhibitor Therapy
por: Goh, Myung Ji, et al.
Publicado: (2020) -
Prognostic significance of cachexia index in patients with advanced hepatocellular carcinoma treated with systemic chemotherapy
por: Goh, Myung Ji, et al.
Publicado: (2022) -
Impact of Intrahepatic External Beam Radiotherapy in Advanced Hepatocellular Carcinoma Patients Treated with Tyrosine Kinase Inhibitors
por: Goh, Myung Ji, et al.
Publicado: (2023) -
Hepatocellular carcinoma with extrahepatic metastasis: Are there still candidates for transarterial chemoembolization as an initial treatment?
por: Kim, Jihye, et al.
Publicado: (2019) -
Substantial risk of recurrence even after 5 recurrence-free years in early-stage hepatocellular carcinoma patients
por: Kim, Jihye, et al.
Publicado: (2020)